Our results showed a different regional profile of Aβ plaque deposits versus astrogliosis and microgliosis; and supported the specific measurement by 3H-florbetaben, 3H-L-deprenyl, GFAP expression, and 3H-PK11195 binding in AD and control brains. This evidence concerns the gene GFAP and Alzheimer disease.